stockrow
Friday 6 November 2026
Export MMED’s income statement to Excel — free account
MiniMed Group, Inc.
MMED Healthcare Medical Instruments & Supplies
MiniMed Group, Inc.’s revenue for fiscal 2026 (year ended April 2026) was $3.1 billion, up 14.3% from fiscal 2025.
18.23
1.06
−5.50%
Follow MMED
Alert me
MiniMed Group, Inc. (MMED) EBITDA
MiniMed Group, Inc.'s EBITDA for fiscal 2026 was −$34.0M, compared with −$2.0M in fiscal 2025. Over the twelve months to 31 July 2026 it was −$8.0M. MiniMed Group, Inc. ranks 38th of 47 Medical Instruments & Supplies companies by EBITDA.
EBITDA, annual
Embed this chart
Annual newest first
| Period | EBITDA | Change |
|---|---|---|
| FY2026 | −$34.0M | — |
| FY2025 | −$2.0M | — |
| FY2024 | $61.0M | — |
Quarterly newest first
| Period | EBITDA | Change |
|---|---|---|
| Jul 2026 | $45.0M | — |
| Jan 2026 | −$100.0M | — |
| Jul 2025 | $25.0M | 13.64% |
| Jan 2025 | $22.0M | — |
EBITDA against peers
| Company | EBITDA |
|---|---|
| BLCO Bausch + Lomb Corporation compare | $801.0M |
| NVST Envista Holdings Corporation compare | $428.9M |
| MMSI Merit Medical Systems, Inc. compare | $359.6M |
| STVN Stevanato Group S.p.A. compare | $351.1M |
| ICUI ICU Medical, Inc. compare | $314.2M |
| TFX Teleflex Incorporated compare | $256.2M |
| ATRC AtriCure, Inc. compare | $34.2M |
| MMED MiniMed Group, Inc. | −$8.0M |
| PLSE Pulse Biosciences, Inc compare | −$82.0M |
What EBITDA is
EBITDA shows what a company earns from its operations before interest, taxes and the non-cash charges for depreciation and amortization.
Reported line item
More on MMED
- Revenue
- Net income
- EPS (diluted)
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Shares outstanding
- Book value per share
- The full statement